Innovation meets healthcare
Welcome to Remodeless CV, where innovation meets healthcare to redefine the future of cardiovascular medicine.
Our Expert Medical Team
Founded by Jacob Schneiderman MD, FAHA, Remodeless CV is at the forefront of developing therapeutic solutions for cardiovascular diseases, focusing on the heart, brain, and blood vessels. Our team, including leading experts in interventional cardiology and surgery, is dedicated to translating our research into clinical settings to combat the devastating effects of vascular diseases.
Our Comprehensive approach
At Remodeless CV, we counteract reprefusion injury, significantly reducing heart failure rates post-MI, minimizing neurological damage after ischemic strokes, and enhancing the viability of transplanted organs.
Innovative Therapies for a Healthier Tomorrow
Our novel approach aims to mitigate reperfusion injury—a common yet untreated phenomenon in acute cardiovascular events like myocardial infarction and ischemic strokes.
unparalleled success
Through extensive research and successful proof-of-concept studies, Remodeless CV has demonstrated unparalleled efficacy in protecting against reperfusion injury, setting new standards in cardiovascular care.
Pioneering Research Protected
Our robust portfolio of US and European patents underlines our commitment to innovation and excellence.